2C-YN: Difference between revisions
Content deleted Content added
Added CSID, (std)InChI, and (std)InChIkey |
Moved the placement of the stub notice to the very bottom and fixed the spacing. |
||
(33 intermediate revisions by 17 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{cs1 config|name-list-style=vanc}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| image = 2C-YN_skeletal.svg |
| image = 2C-YN_skeletal.svg |
||
| width = 200 |
| width = 200 |
||
<!--Clinical data--> |
|||
| tradename = |
|||
<!--Identifiers--> |
<!--Identifiers--> |
||
| legal_UK = Class A |
|||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 752982-24-4 |
| CAS_number = 752982-24-4 |
||
| CAS_supplemental = <BR> 633290-73-0 |
|||
| PubChem = |
| PubChem = 12063400 |
||
⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|||
⚫ | |||
| UNII_Ref = {{fdacite|changed|FDA}} |
|||
| UNII = 5L67256F94 |
|||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=12 | H=15 | N=1 | O=2 |
| C=12 | H=15 | N=1 | O=2 |
||
| molecular_weight = 205.252 g/mol |
|||
| smiles = COc1cc(CCN)c(OC)cc1C#C |
| smiles = COc1cc(CCN)c(OC)cc1C#C |
||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|||
| |
| StdInChI = 1S/C12H15NO2/c1-4-9-7-12(15-3)10(5-6-13)8-11(9)14-2/h1,7-8H,5-6,13H2,2-3H3 |
||
| InChIKey = MLJHHYIJBZVUEA-UHFFFAOYAX |
|||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|||
| StdInChI = 1S/C12H15NO2/c1-4-9-7-12(15-3)10(5-6-13)8-11(9)14-2/h1,7-8H,5-6,13H2,2-3H3 |
|||
| |
| StdInChIKey = MLJHHYIJBZVUEA-UHFFFAOYSA-N |
||
}} |
}} |
||
'''2C-YN''' is an analogue of the [[phenethylamine]] derived hallucinogen [[2C-E]] where the ethyl group has been replaced by an ethynyl group. It has similar potency to [[2C-B]] but a short duration of action.<ref>Trachsel D. Synthesis of Novel (Phenylalkyl)amines for the Investigation of Structure-Activity Relationships. Part 3. 4-Ethynyl-2,5-dimethoxyphenethylamine (4-Ethynyl-2,5-dimethoxybenzeneethanamine; 2C-YN) ''Helvetica Chimica Acta'' 2003; 86:2754-2759.</ref> |
|||
'''2C-YN''' is an [[structural analog|analog]] of [[phenethylamine]] that can be synthesized from [[2C-I]].<ref>{{cite journal | vauthors = Trachsel D | title = Synthesis of Novel (Phenylalkyl) amines for the Investigation of Structure–Activity Relationships, Part 3: 4-Ethynyl-2,5-dimethoxyphenethylamine (= 4-Ethynyl-2, 5-dimethoxybenzeneethanamine; 2C-YN). | journal = Helvetica Chimica Acta | date = August 2003 | volume = 86 | issue = 8 | pages = 2754–2759 | doi = 10.1002/hlca.200390224 }}</ref> Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-YN, although Daniel Trachsel lists it as having a dosage of around 50mg and a duration of around 2 hours, with relatively mild psychedelic effects.<ref>{{cite book | vauthors = Trachsel D, Lehmann D, Enzensperger C | title = Phenethylamine Von der Struktur zur Funktion | page = 768 | publisher = Nachtschatten Verlag AG | date = 2013 | isbn = 978-3-03788-700-4 }}</ref> |
|||
⚫ | |||
==Legality== |
|||
===Canada=== |
|||
As of October 31st, 2016; 2C-YN is a controlled substance (Schedule III) in Canada.<ref>{{cite web | title = Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines) | url = http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php | date = 4 May 2016 | work = Canada Gazette }}</ref> |
|||
== See also == |
|||
* [[2C-AL]] |
|||
* [[2C-E]] |
|||
* [[2C-CP]] |
|||
* [[2C-V]] |
|||
⚫ | |||
{{reflist}} |
{{reflist}} |
||
⚫ | |||
{{Hallucinogenic phenethylamines}} |
{{Hallucinogenic phenethylamines}} |
||
[[Category:2C (psychedelics)]] |
[[Category:2C (psychedelics)]] |
||
[[Category: |
[[Category:Ethynyl compounds]] |
||
⚫ |